Can national health insurance to cover Revlimid?

Published: 2013-04-29 07:00:00

Updated: 2013-04-29 07:00:00

Patients with multiple myeloma have pinned high hopes that Revlimid (lenalidomide) may be covered by national health insurance this year as the recent survey showed that a number of people want more high-priced cancer drug to be included in an insurance list.

Celgene's multiple myeloma drug wa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK